Home » Topics » BioWorld Science

BioWorld Science
RSS

Antibody discovery platform increases cancer immunotherapy targets

Nov. 8, 2021

Novel small molecule K+ secretagogue RDX-013 for treating hyperkalemia

Nov. 8, 2021

Analysis of lung phenotype in rat CF models using flexiVent and X-ray velocimetry

Nov. 8, 2021

STAR-0215, a potent and long-acting MAb plasma kallikrein inhibitor for the treatment of HAE

Nov. 8, 2021

RBT-9 shown effective against BK virus infection

Nov. 8, 2021

Novel UOX-iKO mouse as model of hyperuricemia

Nov. 8, 2021

Viking Therapeutics' dual GLP-1/GIP receptor agonists show potential in model of obesity

Nov. 8, 2021

Mineralocorticoid receptor antagonism ameliorates DKD phenotype in mice

Nov. 8, 2021

New JAK inhibitors patented by Gossamer Bio

Nov. 8, 2021

Aryl hydrocarbon receptor modulators discovered at Dong-A ST

Nov. 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...